Contact Project

11th Dec 2020

The Pancreatic Society of Great Britain and Ireland is to host a major new study. 

The SARS-CoV-2 pandemic has had an unprecedented impact on healthcare systems, with near paralysis of non-COVID-related services during the peak of the pandemic. Pancreatic cancer is aggressive, often presenting late, with the majority of patients presenting with unresectable disease. With service disruption caused by the pandemic, there are concerns that patients with pancreatic cancer did not receive optimal treatment.

The impact is currently unknown, but may have led to delays in diagnosis, modified chemotherapy regimens, [more-rapid] disease progression, and some patients offered no treatment at all. It is essential to understand the impact of these alterations to diagnosis and treatment caused by the SARS-CoV-2 pandemic for this COVID-generation of patients in anticipation of a second-surge, or future pandemics.

Click here to visit the Contact Project home page